9404 ORAL Long-term Survival on S0033 – a Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate at Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumours (GISTs)

✍ Scribed by Blanke, C.; Rankin, C.; Benjamin, R.S.; Raymond, A.K.; Heinrich, M.C.; Fletcher, C.D.M.; Crowley, J.; Borden, E.C.; Demetri, G.D.; Baker, L.H.

• Book ID: 122042919
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 41 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)72548-5